Sleep Center, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Nephrol Dial Transplant. 2011 Jul;26(7):2250-6. doi: 10.1093/ndt/gfq650. Epub 2010 Oct 18.
Cardiovascular disease (CVD) is the leading cause of death among chronic kidney disease (CKD) patients. Vascular calcification is highly prevalent in this population and is an independent predictor of cardiovascular mortality. Vascular calcification in uraemic patients is known to be an active and regulated process subject to the action of many promoting and inhibitory factors. The role of vitamin D in this process remains controversial. We evaluated the relationship between serum levels of 25-hydroxyvitamin D (25(OH)D) and vascular calcification evaluated by plain X-ray images, in predialysis patients with CKD stages 4 and 5.
We performed a cross-sectional study with 210 CKD patients stages 4 and 5 managed at our predialysis unit. Patients were 63.5 ± 13 years of age, 60.5% males, 64.8% diabetics and 47.1% with a history of CVD. Plain X-ray images of pelvis, hands and lateral lumbar spine from all subjects were studied for calculation of semiquantitative vascular calcification scores as described by Adragao and Kauppila.
We found a high prevalence of vascular calcification in our population. Adragao scores revealed only 47 patients (22.4%) without vascular calcification and 120 (57.1%) with scores higher than 3. Kauppila scores revealed only 29 patients (13.8%) without aortic calcifications and 114 patients (54.3%) with scores higher than 7. Higher vascular calcification scores were related to older age, diabetes, history of CVD and lower levels of 25(OH)D. Only 18.5% of patients had adequate levels of 25(OH)D (> 30 ng/mL), 53.7% of them had insufficient levels (15-30 ng/mL) and 27.8% had deficient levels (< 15 ng/mL). Multivariate analysis showed that age, diabetes and CVD were directly associated and 25(OH)D levels were inversely associated with vascular calcifications.
Our results show an independent and negative association between serum levels of 25(OH)D and vascular calcification. Further and larger prospective studies are needed to clarify the possible role of vitamin D deficiency in the development of vascular calcification in CKD patients.
心血管疾病(CVD)是慢性肾脏病(CKD)患者死亡的主要原因。血管钙化在该人群中非常普遍,是心血管死亡率的独立预测因子。已知尿毒症患者的血管钙化是一个活跃且受调节的过程,受许多促进和抑制因素的作用。维生素 D 在这个过程中的作用仍然存在争议。我们评估了血清 25-羟维生素 D(25(OH)D)水平与通过普通 X 射线图像评估的血管钙化之间的关系,研究对象为我们的透析前单位中 CKD 4 期和 5 期的 210 名患者。
我们进行了一项横断面研究,纳入了 210 名 CKD 4 期和 5 期的透析前患者。患者年龄 63.5 ± 13 岁,60.5%为男性,64.8%为糖尿病患者,47.1%有 CVD 病史。对所有受试者的骨盆、手部和侧腰椎的普通 X 射线图像进行研究,以计算 Adragao 和 Kauppila 描述的半定量血管钙化评分。
我们发现我们人群中的血管钙化患病率很高。Adragao 评分仅显示 47 名(22.4%)患者无血管钙化,120 名(57.1%)患者评分高于 3。Kauppila 评分仅显示 29 名(13.8%)患者无主动脉钙化,114 名(54.3%)患者评分高于 7。较高的血管钙化评分与年龄较大、糖尿病、CVD 病史和较低的 25(OH)D 水平相关。仅有 18.5%的患者 25(OH)D 水平充足(>30ng/mL),53.7%的患者 25(OH)D 水平不足(15-30ng/mL),27.8%的患者 25(OH)D 水平缺乏(<15ng/mL)。多变量分析显示,年龄、糖尿病和 CVD 与血管钙化直接相关,25(OH)D 水平与血管钙化呈负相关。
我们的结果显示血清 25(OH)D 水平与血管钙化之间存在独立的负相关。需要进一步和更大规模的前瞻性研究来阐明维生素 D 缺乏在 CKD 患者血管钙化发展中的可能作用。